Active Stocks: Abercrombie & Fitch Co. (NYSE:ANF), Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), MAG Silver Corp. (NYSEMKT:MVG), Fastenal Company (NASDAQ:FAST),

Abercrombie & Fitch Co. (NYSE:ANF) reported that on February 19, 2016, the Board of Directors declared a quarterly cash dividend of $0.20 per share on the Class A Common Stock of Abercrombie & Fitch Co., payable on March 14, 2016 to stockholders of record at the close of business on March 4, 2016.

Abercrombie & Fitch Co. (NYSE:ANF) belongs to Services sector. Its net profit margin is 0.60% and weekly performance is 9.39%. On last trading day company shares ended up at $30.41. Abercrombie & Fitch Co. (NYSE:ANF) distance from 50-day simple moving average (SMA50) is 15.50%.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), will present a corporate overview and business update at the upcoming 36th Annual Cowen & Company Global Healthcare Conference, and the 28th Annual ROTH Conference on 7 and 15 march.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) shares increased 7.56% in last trading session and ended the day at $3.70. OHRP return on assets is -44.30%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) quarterly performance is -17.59%.

MAG Silver Corp. (NYSE MKT:MVG) announces that it has completed its previously announced bought deal financing and has issued 8,905,000 common shares at US$7.30 per share, for gross proceeds of US$65,006,500 (the “Offering”). The Offering was conducted by a syndicate of underwriters led by Scotia Capital Inc., BMO Nesbitt Burns Inc. and Raymond James Ltd. (collectively, the “Lead Underwriters”), and including Macquarie Capital Markets Canada Ltd., National Bank Financial Inc., TD Securities Inc., Cormark Securities Inc., Desjardins Securities Inc. and PI Financial Corp. (together with the Lead Underwriters, the “Underwriters”).

On 02 March, MAG Silver Corp. (NYSEMKT:MVG) shares increased 3.01% and was closed at $7.18. MVG EPS growth in last 5 year was 14.90%. MAG Silver Corp. (NYSEMKT:MVG) year to date (YTD) performance is 1.70%.

On February 23, 2016, Fastenal Company (NASDAQ:FAST) signed an agreement to lease a significant number of industrial vending lockers to one of our customers. This agreement will primarily involve lockers for ‘check-in/check-out’ activities.

Fastenal Company (NASDAQ:FAST) ended the last trading day at $46.50. Company weekly volatility is calculated as 2.09% and price to cash ratio as 104.00. Fastenal Company (NASDAQ:FAST) showed a weekly performance of 4.49%.

On 23 February, Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) announced financial results for the fourth quarter and full year ended December 31, 2015. Adamas reported a net loss attributable to common stockholders of $51.8 million, or $2.86 per share, for the year ended December 31, 2015. In the prior year, the company reported net income attributable to common stockholders of $9.1 million, or $0.53 per diluted share, as a result of $55.0 million of development milestones from Forest Laboratories Holdings Limited (“Forest”) recorded as revenue during the year ended December 31, 2014.

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) shares increased 5.45% in last trading session and ended the day at $13.92. ADMS return on assets is -37.10%. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) quarterly performance is -12.84%.

Leave a Reply

Your email address will not be published. Required fields are marked *